Forte Biosciences Inc (FBRX NASDAQ) stock market data APIs
$7.3598
-0.18(-2.4%)
as of April 30, 2025
Forte Biosciences Inc Financial Data Overview
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Prev. Close
7.3598
Open
7.1752
High
7.3598
Low
6.9033
52 wk Range
4.11-28.68
Market Cap
48 329 K
Shares Outstanding
6 582 K
Beta
2.857
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Forte Biosciences Inc data using free add-ons & libraries
Get Forte Biosciences Inc Fundamental Data
Forte Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -36 563 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-12-31
- EPS/Forecast: -2.36
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Forte Biosciences Inc News
New
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
-FB-102 Has Demonstrated Potentially Best in Class Activity including Superiority to Standard of Care in GvHD -Proof of Concept Pre-clinical Data in Additional Indications with Large Market Potential...
Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors
Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation Committee Board member Vishal Kapoor appointed to Jasper Audit and Compensation Committees RED...
Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors
Jasper Therapeutics Dr. Brun also appointed as Chairperson of Jasper Research and Development Committee and to Compensation Committee Board member Vishal Kapoor appointed to Jasper Audit and Compens...
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
DALLAS, May 19, 2023--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced the issuance of an equit...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
